Vanesa Dávalos-Yerovi

Dr. Vanesa Dávalos-Yerovi

Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Delky Meza-ValderramaDelky Meza-Valderrama
Delky Meza-Valderrama
EMEster Marco
Ester Marco
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
MMMaria Dolors Muns
Maria Dolors Muns
MTMarta Tejero-Sánchez
Marta Tejero-Sánchez
DSDolores Sánchez-Rodríguez
Dolores Sánchez-Rodríguez
The recent publication of the revised Consensus on definition and diagnosis of sarcopenia (EWGSOP2) and the Global Leadership Initiative on Malnutrition (GLIM) criteria changed the approach to research on sarcopenia and malnutrition. Whilst sarcopenia is a nutrition-related disease, malnutrition and cachexia are nutritional disorders sharing the common feature of low fat-free mass. However, they have differential characteristics and etiologies, as well as specific therapeutic approaches. Applying the current definitions in clinical practice is still a challenge for health professionals and the potential for misdiagnosis is high. This is of special concern in the subgroup of older people with cancer, in which sarcopenia, malnutrition, and cancer cachexia are highly prevalent and can overlap or occur separately. The purpose of this review is to provide an updated overview of the latest research and consensus definitions of sarcopenia, malnutrition, and cachexia and to discuss their implications for clinical practice in older patients with cancer. The overall aim is to improve the quality of nutritional care in light of the latest findings.

26 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
EMEster Marco
Ester Marco
DSDolores Sánchez-Rodríguez
Dolores Sánchez-Rodríguez
XDXavier Duran
Xavier Duran
Delky Meza-ValderramaDelky Meza-Valderrama
Delky Meza-Valderrama
EDEsther Duarte
Esther Duarte
Malnutrition has a negative impact on patients with chronic pulmonary obstructive disease (COPD). The purpose of this study was to assess the prevalence of malnutrition, defined by the Global Leadership Initiative for Malnutrition (GLIM), in stable COPD patients referred to pulmonary rehabilitation, and to explore potential associations of malnutrition according to GLIM, and its components, with increased risk of mortality and hospitalizations in 2 years. In a post-hoc analysis of a prospective cohort of 200 rehabilitation patients with stable COPD, main outcome variables were hospital admissions, length of stay, and mortality during a 2-year follow-up. Covariates were malnutrition according to GLIM and its phenotypic criteria: unintentional weight loss, low body mass index (BMI), and low fat-free mass (FFM). Univariate and multivariate analysis were performed using logistic and proportional hazard Cox regression. Malnutrition according to GLIM showed 45% prevalence and was associated with increased mortality risk. Low age-related BMI and FFM were independently associated with mortality, which persisted after adjustment for age and lung function. Malnutrition and low BMI were also associated with increased risk of hospitalization. Malnutrition according to GLIM criteria was highly prevalent in rehabilitation patients with COPD and was associated with nearly 3 times greater mortality and hospitalization risk.

1 August 2019 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
EMEster Marco
Ester Marco
DSDolores Sánchez-Rodríguez
Dolores Sánchez-Rodríguez
AGAnna Guillen-Solà
Anna Guillen-Solà
XDXavier Duran
Xavier Duran
EDEsther Duarte
Esther Duarte

3 January 2022 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
PSPérez- Sáez
Pérez- Sáez
MJMaría José
María José
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
DRDolores Redondo-Pachón
Dolores Redondo-Pachón
CACarlos Arias-Cabrales
Carlos Arias-Cabrales
JPJulio Pascual
Julio Pascual
Background Frailty is common among advanced chronic kidney disease (CKD) patients who are kidney transplant (KT) candidates, and predisposes to poor outcomes after transplantation. However, frailty is not routinely measured during pretransplant work-up and it is unknown which metric should be used in this specific population. Our aim was to establish frailty prevalence in KT candidates according to different frailty scales. Methods Prospective longitudinal study of 451 KT candidates evaluated for frailty by both Physical Frailty Phenotype (PFP) and FRAIL scale at the time of inclusion on the KT waiting list. Clinical and functional characteristics including sociodemographics, comorbidities, disability and nutritional status were recorded. Agreement between PFP and FRAIL scales as well as dissonant patients were analyzed. Results Mean age was 60.9 years and 31.7% were female. Comorbidity burden among patients was high, with 36.9% and 16.2% presenting with diabetes and ischemic coronary disease, respectively. Disabilities were also frequent. More than 70% of patients presented with ≥ 1 PFP criteria while this percentage for ≥ 1 FRAIL criteria was 45.4%. Agreement between PFP and FRAIL was not good (kappa index 0.317). There were 132 patients who were pre-frail or frail according to PFP but non-frail according to the FRAIL scale and they presented with fewer comorbidities and less disability. Conclusions Frailty is frequent in advanced CKD patients, although its prevalence may vary according to different scales. Agreement between PFP and FRAIL scale is not good, and FRAIL scale might misclassify as robust patients those frail/prefrail patients who are in better health conditions. Graphical abstract

7 July 2023 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
MPMaria José Pérez‐Sáez
Maria José Pérez‐Sáez
AFAnna Faura‐Vendrell
Anna Faura‐Vendrell
MMMaria Dolors Muns‐Cornellas
Maria Dolors Muns‐Cornellas
XDXavier Duran
Xavier Duran
TGthe FRAILMar Study Group
the FRAILMar Study Group

9 July 2024 in Rehabilitación
Verified
Journal Article
Closed access
VDVanesa Dávalos-Yerovi
Vanesa Dávalos-Yerovi
AGA. Gómez-Garrido
A. Gómez-Garrido
RGR. Garcia-Gutiérrez
R. Garcia-Gutiérrez
CBC. Berastegui
C. Berastegui
VPV. Pujol-Blaya
V. Pujol-Blaya
DSD. Sánchez-Rodríguez
D. Sánchez-Rodríguez